Lithotripsy Devices Market Size & Growth Forecast 2027–2036, By Segments (Type, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to content
Market Size and Growth Outlook
Lithotripsy Devices Market size was over USD 1.49 billion in 2026 and is likely to grow at a 6.08% CAGR between 2027 and 2036, attaining USD 2.69 billion by 2036. The industry revenue for 2027 is assessed at USD 1.57 billion.
Get more details on this report
Request Free Sample ReportLithotripsy Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America leads the market through established hospital networks, high urology procedure volumes, advanced technology adoption, and steady demand for equipment upgrades across care settings.
- Asia Pacific is projected to grow at a 7.35% CAGR, supported by expanding hospital infrastructure, broader access to urology care, and increasing adoption of modern minimally invasive stone treatment procedures.
Segment Momentum
- Extracorporeal Shock Wave Lithotripsy Devices captured a 53.55% share in 2026 because their non-invasive approach supports efficient treatment, broad clinical adoption, and high patient throughput across healthcare settings.
- Ambulatory Surgical Centers are the fastest-growing end-use segment as more lithotripsy procedures shift toward efficient outpatient care with streamlined scheduling, shorter stays, and focused procedural delivery.
Market Expansion Drivers
- Rising kidney stone prevalence increasing demand for minimally invasive lithotripsy procedures.
- Technological advancements improving precision and safety of next-generation lithotripsy devices.
- Expansion of ambulatory surgical centers supporting outpatient lithotripsy treatment adoption.
Leading Market Participants
- Prominent companies in the lithotripsy devices market include Boston Scientific Corporation (United States), Olympus Corporation (Japan), Dornier MedTech GmbH (Germany), Richard Wolf GmbH (Germany), STORZ MEDICAL AG (Switzerland), Medispec Ltd. (Israel), BTL Industries Inc. (United States), Zimmer MedizinSysteme GmbH (Germany), Shenzhen Huikang Medical Apparatus Co., Ltd. (China), MTS Medical UG (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.49 billion
- 2027 Estimated Market Size: USD 1.57 billion.
- Projected Market Size: USD 2.69 billion by 2036
- Growth Forecast: 6.08% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Extracorporeal Shock Wave Lithotripsy Devices (Type) | Hospitals (End-use) | Kidney Stones (Application)
- Emerging Opportunity Segment: Intracorporeal Lithotripsy Devices (Type) | Ambulatory Surgical Centers (End-use) | Pancreatic Stones (Application)
Market Growth Drivers and Industry Trends
Rising kidney stone prevalence increasing demand for minimally invasive lithotripsy procedures
Increasing kidney stone prevalence is supporting the lithotripsy devices market as healthcare providers seek minimally invasive approaches for stone treatment. Lithotripsy procedures can address kidney stones without relying on more invasive surgical interventions, strengthening demand for devices used in clinical settings where less invasive treatment options are prioritized.
Technological advancements improving precision and safety of next-generation lithotripsy devices
Technological advancements are contributing to the lithotripsy devices market by improving the precision and safety of newer treatment systems. Enhanced device capabilities can support more controlled stone targeting and treatment delivery, helping healthcare providers adopt advanced lithotripsy technologies where procedural accuracy and patient safety are important considerations.
Expansion of ambulatory surgical centers supporting outpatient lithotripsy treatment adoption
The expansion of ambulatory surgical centers is creating favorable conditions for the lithotripsy devices market by increasing the availability of outpatient treatment environments. As these facilities support procedures outside traditional inpatient settings, lithotripsy can be incorporated into more streamlined treatment pathways where appropriate, encouraging the use of dedicated devices for outpatient stone management.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing prevalence of kidney stones and urological conditions | 2.10% | Short term (≤ 2 yrs) | North America, Europe | Medium | Fast |
| Expansion of minimally invasive lithotripsy procedures | 2.20% | Medium term (2–5 yrs) | Europe, Asia Pacific | Medium | Moderate |
| Innovation in lithotripsy device design and efficiency | 2.20% | Long term (5+ yrs) | North America, Asia Pacific | Medium | Moderate |
| Rising kidney stone prevalence increasing demand for minimally invasive lithotripsy procedures | 2.00% | Moderate | North America, Asia Pacific | High | Near Term |
| Technological advancements improving precision and safety of next-generation lithotripsy devices | 1.80% | Moderate | Europe, North America | High | Mid Term |
| Expansion of ambulatory surgical centers supporting outpatient lithotripsy treatment adoption | 1.50% | Moderate | North America, Europe | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the lithotripsy devices market in 2026, supported by advanced urological care infrastructure, established specialist networks, and strong adoption of minimally invasive treatment technologies. The availability of sophisticated medical facilities enables healthcare providers to perform stone-removal procedures using advanced lithotripsy systems, while increasing emphasis on less invasive interventions supports technology adoption. Continued healthcare investment and improvements in procedural capabilities further reinforce demand for specialized stone-treatment devices.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, increasing prevalence and awareness of urinary stone conditions, and improving access to specialized urological treatment. Healthcare modernization is enabling hospitals to adopt advanced minimally invasive technologies, while growing investment in diagnostic and therapeutic capabilities is broadening access to lithotripsy procedures. Rising demand for efficient stone-management solutions and increasing availability of specialist care are creating favorable conditions for regional market growth.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
Germany 🇩🇪
Precision Urology SystemsGermany emphasizes lithotripsy devices offering reliable performance and integration with advanced urology practices. Medical equipment manufacturers continue refining imaging capabilities and treatment accuracy to support specialized clinical procedures.
France 🇫🇷
Clinical Workflow OptimizationFrance is strengthening lithotripsy device utilization by improving access to minimally invasive stone management in hospitals. Procurement decisions increasingly favor systems offering dependable imaging integration and efficient clinical workflows.
Italy 🇮🇹
Specialized Urology ExpansionItaly is expanding lithotripsy device deployment across specialized urology centers seeking effective non-invasive treatment options. Equipment suppliers are focusing on user-friendly systems that support consistent procedural performance and patient care quality.
Japan 🇯🇵
Compact Treatment TechnologiesJapan is advancing lithotripsy device adoption through compact, high-performance systems suited to technologically advanced healthcare facilities. Clinical priorities include patient comfort, procedural efficiency, and consistent treatment outcomes.
South Korea 🇰🇷
Hospital Technology UpgradesSouth Korea continues modernizing urology departments with lithotripsy devices that enhance precision and operational efficiency. Healthcare providers are investing in integrated treatment platforms supporting streamlined diagnosis and intervention.
United States 🇺🇸
Minimally Invasive CareThe U.S. lithotripsy devices market is driven by growing preference for minimally invasive kidney stone treatment and continual hospital technology upgrades. Healthcare providers are adopting advanced systems that improve treatment precision, workflow efficiency, and patient recovery.
Lithotripsy Devices Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Extracorporeal Shock Wave Lithotripsy Devices (Largest Segment) vs Intracorporeal Lithotripsy Devices (Fastest-Growing Segment)
Extracorporeal shock wave lithotripsy devices dominated the lithotripsy devices market, accounting for a 53.55% share in 2026. Their leading position is supported by the non-invasive nature of the procedure, which enables kidney and urinary stone fragmentation without requiring direct surgical access to the stone. The established use of shock wave technology, broad clinical familiarity, and suitability for treating eligible patients continue to support demand. Growing awareness of minimally invasive treatment options is also reinforcing the role of extracorporeal lithotripsy in urological care.
Intracorporeal lithotripsy devices are experiencing the fastest growth as advancements in endoscopic procedures expand the use of direct stone fragmentation techniques. These devices enable physicians to target stones within the urinary tract with greater procedural control, making them valuable for patients requiring precise intervention. Increasing adoption of minimally invasive urological procedures, improvements in endoscopic equipment, and growing demand for effective treatment of complex or difficult-to-access stones are supporting greater utilization of intracorporeal lithotripsy technologies.
End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Hospitals held the largest share of the lithotripsy devices market, representing 48.44% in 2026. Hospitals remain major centers for urological diagnosis and treatment because they provide specialized surgical infrastructure, advanced imaging capabilities, and multidisciplinary clinical support. Lithotripsy procedures often require access to comprehensive diagnostic and emergency care resources, particularly when patients present with complex stone conditions. Continued investment in advanced urological services and minimally invasive treatment capabilities is therefore sustaining demand for lithotripsy devices in hospital settings.
Ambulatory surgical centers are the fastest-growing end-use segment as healthcare delivery increasingly shifts toward outpatient and minimally invasive procedures. These facilities can provide specialized interventions in a more streamlined setting, supporting shorter care pathways and greater procedural convenience for appropriate patients. Increasing physician and patient preference for outpatient treatment, together with improvements in lithotripsy and related urological technologies, is creating favorable conditions for greater adoption of these devices in ambulatory surgical environments.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Extracorporeal Shock Wave Lithotripsy Devices, Intracorporeal Lithotripsy Devices | Extracorporeal Shock Wave Lithotripsy Devices | Intracorporeal Lithotripsy Devices |
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Application | Kidney Stones, Ureteral Stones, Pancreatic Stones, Bile Duct Stones | Kidney Stones | Pancreatic Stones |
Competitive Landscape and Market Positioning
Prominent players in the lithotripsy devices market:
1. Boston Scientific Corporation (United States)
2. Olympus Corporation (Japan)
3. Dornier MedTech GmbH (Germany)
4. Richard Wolf GmbH (Germany)
5. STORZ MEDICAL AG (Switzerland)
6. Medispec Ltd. (Israel)
7. BTL Industries Inc. (United States)
8. Zimmer MedizinSysteme GmbH (Germany)
9. Shenzhen Huikang Medical Apparatus Co. Ltd. (China)
10. MTS Medical UG (Germany)
Minimally invasive treatment demand is driving innovation in the lithotripsy devices market. In the lithotripsy devices market, precision energy delivery systems and improved procedural control are enhancing treatment efficiency and patient recovery.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Boston Scientific Corporation (United States) | |||||||
| Olympus Corporation (Japan) | |||||||
| Dornier MedTech GmbH (Germany) | |||||||
| Richard Wolf GmbH (Germany) | |||||||
| STORZ MEDICAL AG (Switzerland) | |||||||
| Medispec Ltd. (Israel) | |||||||
| BTL Industries Inc. (United States) | |||||||
| Zimmer MedizinSysteme GmbH (Germany) | |||||||
| Shenzhen Huikang Medical Apparatus Co. Ltd. (China) | |||||||
| MTS Medical UG (Germany). |
Industry Development / News
| Company Name | Date | Key Development |
|---|---|---|
| Avvio Medical | May-25 | Avvio Medical reported first patient treatments using its investigational Enhanced Lithotripsy System following FDA IDE approval. The milestone advances clinical validation of next-generation lithotripsy technology designed to improve kidney stone fragmentation and minimally invasive treatment outcomes. |
| Shvabe Holding | Dec-24 | Shvabe Holding unveiled a certified extracorporeal shock-wave lithotripter aimed at replacing imported systems in Russian clinical settings. The development supports domestic medical device production and expands access to lithotripsy technologies in local healthcare infrastructure. |
| SonoMotion | Nov-24 | SonoMotion received FDA de-novo clearance for its Stone Clear device, an ultrasound-based platform designed to mobilize residual stone fragments post-lithotripsy. The approval expands post-procedure treatment capabilities and enhances non-invasive stone management workflows. |
| Boston Scientific Corporation | Mar-21 | Boston Scientific acquired Lumenis, expanding its presence in lithotripsy and minimally invasive urology treatment solutions. The acquisition strengthens its portfolio in energy-based medical devices and supports broader adoption of advanced stone treatment technologies across global healthcare markets. |
| Dornier MedTech | Mar-21 | Dornier MedTech achieved EU MDR certification for its Class IIb lithotripsy systems, including the Delta III lithotripter and UIMS platform. The certification enhances regulatory compliance and strengthens its competitive positioning in the European medical device market for extracorporeal shock wave lithotripsy systems. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Lithotripsy Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Energy Source | Shock Wave, Laser, Pneumatic, Ultrasonic, Electrohydraulic |
| Patient Age Group | Pediatric, Adult, Geriatric |
| Device Utilization Model | Reusable Systems, Single-Use Systems, Hybrid Systems |
Lithotripsy Devices Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Treatment Pathway Optimization Analysis |
|
| Clinical Workflow Integration Assessment |
|
| Reimbursement and Healthcare Economics Analysis |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the market valuation of lithotripsy devices?
What is the projected value of the lithotripsy devices industry by 2036?
How is the shift toward minimally invasive treatment pathways influencing adoption of lithotripsy devices?
How are technological advancements and the expansion of ambulatory surgical centers reshaping lithotripsy device purchasing decisions?
Why are Extracorporeal Shock Wave Lithotripsy Devices the leading segment in the lithotripsy devices market?
Which end-use segment is growing fastest in the lithotripsy devices market?
What factors make North America the largest lithotripsy devices market?
Why is Asia Pacific experiencing the fastest growth in the lithotripsy devices market?
Which companies dominate the lithotripsy devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook